trending Market Intelligence /marketintelligence/en/news-insights/trending/l6qtgwxvi-unbav1kubv_g2 content esgSubNav
In This List

Proteostasis withdraws stock offering due to market conditions

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Proteostasis withdraws stock offering due to market conditions

Proteostasis Therapeutics Inc. withdrew its previously announced underwritten public offering of 9 million common shares.

The Cambridge, Mass.-based biopharma company said "current market conditions are not conducive for an offering."